Pressed by industry lobbyists, White House officials on Wednesday assured drug makers that the administration stood by a behind-the-scenes deal to block any Congressional effort to extract cost savings from them beyond an agreed-upon $80 billion.
White House Affirms Deal on Drug Cost
The U.S. government has given an ultimatum to the international group that helps provide vaccines to...
